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Abstract Microsomal and soluble peptidases from bovine liver 
and pig brain hydrolyze the farnesylated, Ras-based CAAX 
peptide [3H]Ac-fCVIM-OH. However, they differ in their 
sensitivity to substrate-based inhibitors, sulfhydryl and chelating 
agents, pH and ionic strength optima, and stability. The 
microsomal activity was exquisitely sensitive to the substrate- 
based inhibitor Boc-fC[CH2]VIM-OH, moderately sensitive to 
the sulfhydryl agent pCMB, but insensitive to NEM and the 
metal-chelating agent o-phenanthroline. The soluble activity was 
insensitive to Boc-fC[CH2]VIM-OH, but very sensitive to 
pCMB, NEM and o-phenanthroline, suggesting it to be the 
previously reported (Biochem. Biophys. Res. Conlmun. 198, 787- 
794 (1994)) zinc metallopeptidase. The microsomal activity is 
most likely to be a cysteine peptidase involved in the post- 
translational processing of Ras proteins. 
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Recently, two enzymes that cleave AAX from farnesyl- 
CAAX-containing peptides have been reported. The first 
was from bovine liver microsomes and cleaved the tetrapep- 
tide [3H]Ac-fCVIM-OH [15,16], while the second was from 
pig brain and cleaved the heptapeptide propionyl-GSP-fC- 
[3H]VLM-OH [17]. The pig brain enzyme was a thiol-depend- 
ent zinc metallopeptidase, based on its inhibitor profile, and 
could be solubilized by freezing and thawing the microsomes. 
It was of interest to determine whether the soluble metallo- 
peptidase could also hydrolyze [3H]Ac-fCVIM and be inhib- 
ited by Boc-fC[CH2]VIM-OH, a potent substrate-based inhi- 
bitor of the microsomal enzyme [18]. We present evidence 
suggesting that the soluble metallopeptidase has a different 
inhibitor profile, pH and ionic strength optima than the mi- 
crosomal peptidase activity, and the latter is most likely a 
cysteine, Ras-processing peptidase. 
2. Materials and methods 
1. Introduction 
Ras proteins function as molecular switches in the transduc- 
tion of extracellular signals from tyrosine kinases, associated 
with the membrane, to serine/threonine kinases in the cyto- 
plasm [1-3]. The Ras-dependent signal transduction pathways 
control cell proliferation and differentiation depending on the 
cell context [4-8]. Ras proteins cycle between an active, GTP- 
bound form and an inactive, GDP-bound form and are onco- 
genic when constitutively activated; in its oncogenic, mutated 
form, Ras is found in 50% of colorectal and 95% of pancreatic 
human cancers [9]. Critical to Ras function is its processing at 
the C-terminal Cys-aliphatic-aliphatic-any mino acid se- 
quence (CAAX box). Processing involves farnesylation at 
the Cys thiol group, removal of the AAX tripeptide by a 
specific peptidase, and methylation of the exposed Cys car- 
boxyl group [10,11]. Farnesylation is the key reaction for the 
membrane association of Ras and its ability to transform ceils 
[12,13]. Current research as focused on this reaction, and 
potent, selective inhibitors of farnesyltransferase r under 
development [14]. 
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2.1. Mater&Is 
Bovine liver and pig brains were obtained from Pel-Freeze (Rogers, 
AR). DTT, HEPES, NEM, PMSF, pCMB, and famesol were ob- 
tained from Sigma (St. Louis, MO). [3H]Ac-fCVIM-OH (spec. act. 
2.2 laCi/nmol) was synthesized byDr. Satish Choudry of the Radio- 
isotope Synthesis group and Boc-fC[CH2]VIM-OH [18] by Dr. Steve 
Ferguson of the Oncology department. Hydroxyapatite (CHTII), 
methyl HIC, Affigel 501 (an organomercurial agarose gel), and DC 
protein assay kit were from BioRad (Richmond, CA). Dihydroxybor- 
yl-m-phenyl-matrix gel(PBA-60) for boronate affinity column, and 
dye matrix affinity column kit (Blue A, Red A, Orange A, Green A, 
Blue A) were from Amicon (Beverly, MA). HiTrap HIC test kit (phe- 
nyl Sepharose and octyl Sepharose) were from Pharmacia (Piscat- 
away, NJ). Dynamax 60A, 8 ~tm silica gel column (4.3×250 mm) 
and guard column were from Rainin Instruments (Woburn, MA). 
Waters 600E HPLC and WISP 710B were from Millipore Corp. (Bed- 
ford, MA). FLO-ONE for Windows Radio-HPLC workstation soft- 
ware package, IBM PC, Beta Flo-one detector and Ultima M scintil- 
lation cocktail were from Packard Instrument Co. (Meriden, CT). All 
solvents (analytical/HPLC grade) were from Fisher Scientific (Pitts- 
burgh, PA). 
2.2. Preparation of bovine liver and pig brain microsomes 
Bovine liver microsomes were prepared by the method of Ma et al. 
[16] and frozen in aliquots at -70°C. Pig brain microsomes were 
prepared according to Akopyan et al. [17] with the following modifi- 
cations. Pig brain (30 g) was minced in 3 vols. of 50 mM TEA, pH 
7.5, containing 250 mM sucrose, 50 mM potassium acetate, 6 mM 
magnesium acetate, 0.02% sodium azide, 0.1 mM DTT, 0.5 mM 
PMSF, 10 ~tM leupeptin, and 0.05 units/ml aprotinin. The resuspen- 
sion buffer was 25 mM TEA, pH 7.2, 0.1 mM DTT, 0.5 mM ZnC12, 
0.02°/'o sodium azide, 0.5 mM PMSF, 10 ~tM leupeptin, and 0.05 units/ 
ml aprotinin. The ultracentrifugation step did not include a sucrose 
cushion. 
2.3. Solubilization of microsomal peptidase activity by freeze-thawing 
Soluble peptidase activity was prepared from microsomes by the 
method of Akopyan et al. [17]. The frozen microsomes were thawed 
by swirling in a 37°C bath, cooled by stirring in an ice bath, set on ice 
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for 1 h, and centrifuged at 100000×g for 4 h (4°C). The resulting 
supernatant was used immediately in peptidase activity assays. 
2.4. Peptidase activity assay 
Incubation mixtures contained in a total volume of 50 txl: 25 pmol 
of [3H]Ac-fCVIM-OH in 2 ~tl of DMSO, 5 I-tg of peptidase prepara- 
tion, test compound (10-fold concentrated solution in 100% DMSO), 
and assay buffer (200 mM HEPES pH 7.4, 100 mM NaC1, 5 mM 
MgC12). Reactions were initiated with the addition of [3H]Ac-fCVIM- 
OH and, after 60 min at 37°C, terminated with the addition of 0.5 ml 
of chloroform/methanol (1:1, by vol.) followed by 0.5 ml of 1 M citric 
acid for phase separation. The lower, organic layer was collected, 
dried in a SpeedVac (Savant Instruments, Farmingdale, NY) at 
room temperature or 43°C, and analyzed by normal-phase HPLC 
[16,19,20]. Substrate and product peaks were monitored with an on- 
line Flo-one Beta radiochromatography detector using automatic data 
analysis. All assays were performed at least in duplicate. 
2.5. pH and ionic strength profiles 
For the pH profile, 156 mM MES-156 mM HEPES-300 mM 
diethanolamine was used as a single buffer (•=0.30) to separate the 
effects of ionic strength from pH [21]. For the ionic strength profile, 
the buffer used was 26 mM MES-26 mM HEPES-50 mM diethano- 
lamine, pH 7.2 (I= 0.05), and the ionic strength was varied with KC1. 
Effects of buffer ions, phosphate, acetate and Tris were examined 
using 26 mM MES-26 mM HEPES, 50 mM diethanolamine, pH 
7.2, and the appropriate buffer ion at 100 mM (pH 7.2), with ionic 
strength being adjusted to 0.3 with KC1. 
3. Results and discussion 
Hancock et al. [22] reported that microsomal preparations 
from canine pancreas removed the terminal three amino acids 
from Ras in vitro. More recently, Ma and co-workers re- 
ported that microsomal preparations from bovine liver re- 
moved the intact terminal tripeptide from synthetic, farnesy- 
lated tetrapeptide substrates mimicking the C-terminus of Ras 
[15,16] and achieved a modest, partial purification of the mi- 
crosomal enzyme [23]. We also used radiolabeled, farnesylated 
peptides to assay proteolytic activity and infer potential Ras- 
processing peptidase. 
Because microsomal Ras protease activity from bovine liver 
was not amenable to purification by conventional methods, 
we became interested in the freeze-thaw technique of Akyopan 
et al. [17] that released a soluble peptidase activity from pig 
brain microsomes resembling endopeptidase EC 3.4.24.15, a 
thiol-dependent zinc metallopeptidase. We found that this so- 
luble activity could be further purified on organomercurial 
affinity column (Hitz and Georgopapadakou, unpublished re- 
suits). However, its inhibitor profile was different from that of 
the microsomal activity (Table 1). For example, the microso- 
mal activity was exquisitely sensitive to the farnesylated pep- 
tide gap inhibitor Boc-fC[CH2]VIM-OH, relatively resistant to 
the unfarnesylated CAAX peptides Ac-CVIS-OH and Ac- 
CVIM-OH, moderately sensitive to the sulfhydryl agent 
pCMB, and resistant to the metal chelator o-phenanthroline. 
The soluble activity was relatively resistant to Boc- 
fC[CH2]VIM-OH [18], very sensitive to pCMB, and sensitive 
to o-phenanthroline (but not to m-phenanthroline (IC~0 > 1 
mM), a non-chelating isomer). The soluble activity thus re- 
sembled a cytosolic a-factor peptidase from Saccharomyces 
cerevisiae reported previously, although the yeast enzyme 
was insensitive to sulfhydryl agents [24]. With both soluble 
and microsomal activities, the main affinity determinant ap- 
peared to be the farnesyl group, since farnesylated tetrapep- 
tides were better inhibitors than the corresponding onfame- 
sylated tetrapeptides. The specificity of AcfCVIS-OH over 
AcCVIS-OH was > 250-fold for the microsomal activity but 
only ~ 5-fold for the soluble activity suggesting that the for- 
mer may be more relevant to the removal of the C-terminal 
tripeptide from farnesylated Ras. 
Since Akopyan [17] used pig brain microsomes, the inhibi- 
tor specificity of the soluble and microsomal peptidase activ- 
ities from that source were also compared (Table 1). As with 
bovine liver, the soluble activity was resistant to inhibition by 
Boc-fC[CH2]VIM-OH while the microsomal activity was ex- 
quisitely sensitive. Accordingly, the specificity of farnesylated 
over non-farnesylated tetrapeptides (AcfCVIS-OH vs. Ac- 
CVIS-OH) was ,,~2-fold with the soluble but ->21-fold for 
the microsomal peptidase activity. As previously reported 
[17], the soluble activity was sensitive to o-phenanthroline. 
When the preincubation time with o-phenanthroline was in- 
creased to 60 min at room temperature, the IC50 decreased 
from 300 ~tM to < 100 ~tM. In other systems, inhibition by 
EDTA has also been reported to be time dependent [25], 
although in the present study this chelator did not inhibit 
soluble peptidase activity up to 1 raM. It is noted that the 
metalloprotease carboxypeptidase B, though sensitive to o- 
phenanthroline, is also resistant to EDTA [26]. As with bovine 
liver, the soluble peptidase activity from pig brain was more 
sensitive to the sulfhydryl agents pCMB and NEM than was 
the microsomal activity. 
The two peptidase activities from pig brain were next char- 
Table 1 
Inhibitor profiles of soluble and microsomal bovine liver and pig brain peptidase activities using [3H]Ac-fCVIM-OH as substrate 
Compound IC~o (ktM) 
Bovine liver peptidase Pig brain peptidase 
Soluble Microsomal Soluble Microsomal 
Boc-fC[CH2]-VIM- OH > 100 ~ 0.003 (0.086) variable a NA b 0.0047 
AcfCVIS-OH 10 ° 4 c (6 d ) 140 (30 000 e) 10 
AcfCVIM-OH NA 0.5 f (3 d) NA NA NA 
AcCVIS- OH 55 > 1000 NA 103 NA -> 210 
AcCVIM- OH 112 500 NA 79 (< 300 g) 192 
Farnesol NA 30 NA > 100 NA > 100 
o-Phenanthroline 470 >1000 (>600) 300 (100) >1000 
pCMB 2 10 (500 h) 6 (< 10) 38 
NEM NA 500 NA 26 (< 100) > 1000 
Values represent averages from at least wo separate experiments, each involving duplicate assays. Literature values for microsomal bovine liver 
peptidase [18,19] and soluble pig brain peptidase [17] are shown in parentheses. 
~Biphasic nhibition curve; bNA, data not available; CKi; dK m ; eg  m of propionyl-GSPfCVLM-OH; fKi using Ac-[ZH]fCVIS-OH as substrate [19]; 
ginhibition of a soluble yeast a-factor protease by unfarnesylated a-factor [22]; alCs0 for p-hydroxymercuribenzoate. 
312 A.M. Hitz, N.H. Georgopapadakou/FEBS Letters 391 (1996) 310-312 
._> 
E o~ 
x 
=1 
:Z 
100 
80 
60 
40 
2° I
0 
5 
100 
80 
>, - 
"~ 60 
0 
,< 
40 
2o 
4 I I I 0 
6 7 8 9 
pH 
A b 
I 
0.0 0.1 0.2 0.3 0.4 
Ionic Strength 
Fig. 1. pH (A) and ionic strength (B) profiles of pig brain microsomal ((>) and soluble (A) peptidase preparations. In (A), ionic strength was 
kept constant as described in Section 2. In (B), ionic strength was varied with KC1. Points represent averages values from two separate experi- 
ments, each involving duplicate assays. 
acterized with respect o pH and ionic strength optima (Fig. 
1). For the soluble activity, the pH optimum was 7.2-7.4 (Fig. 
IA), similar to that reported for the soluble peptidase from 
pig brain [17] and rat brain [27]. The microsomal activity 
reproducibly exhibited two maxima, at pH 6.8 and 7.6, which 
differ from the single maximum at pH 7.0 reported for the 
microsomal activity from bovine liver [15]. Interestingly, while 
the microsomal activity was not inhibited by any of the buf- 
fers used, the soluble activity was inhibited by the potentially 
chelating phosphate and acetate buffers (IC50 100 mM), con- 
sistent with it being a metallopeptidase. The ionic strength 
optima for the two peptidase activities were also reproducible 
distinct, the soluble activity showing a maximum at higher 
ionic strength than the microsomal activity (Fig. 1B). 
The detergent solubilized [23], microsomal activity was un- 
stable during most chromatography steps (boronate, hydro- 
xyapatite, dye affinity, methyl- phenyl- and octyl-hydrophobic 
interaction chromatography, and organomercurial affinity col- 
umns), resulting in low activity yields (Hitz and Georgopapa- 
dakou, unpublished results). 
In summary, we have compared a microsomal and soluble 
peptidase activity from bovine liver and pig brain and found 
them to be distinct, and the microsomal activity to be most 
likely the relevant, Ras-processing peptidase. It should be 
noted that the microsomal activity may represent more than 
one isozyme [28]. Validation of the Ras-processing activity of 
the microsomal peptidase must await in vitro and in vivo 
studies with appropriately radiolabeled, farnesylated Ras. 
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